Instrument Inactif

Autres langues C-Rad AB OTC Markets

Actions

CRADF

SE0002016352

Equipement et technologie médicale avancés

Autres langues

15/05	C-Rad, SeeTreat partner to deliver radiotherapy
15/05	C-RAD and SeeTreat partner to deliver personalised radiotherapy for every patient
15/05	C-Rad and Seetreat Partner to Deliver Personalised Radiotherapy for Every Patient
13/05	C-RAD marks its new chapter at ESTRO 2026 with clinician-driven SGRT advances
06/05	C-Rad AB Reports Earnings Results for the First Quarter Ended March 31, 2026
06/05	C Rad Q1 adjusted EBIT SEK 22 mln
06/05	C-RAD's Interim Report Q1’26
10/04	C-RAD publishes its annual report for 2025
12/02	C Rad Q4 order intake decreased 10% to SEK 151 mln
12/02	C-RAD's Year-end report Q4'25
12/02	C-Rad AB (OM:CRAD B) commences an Equity Buyback Plan, under the authorization approved on May 8, 2025.
12/02	C-Rad AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025
12/02	C-Rad AB announces Annual dividend, payable on May 15, 2026
29/01	Invitation to presentation of C-RAD’s year-end report and report for the fourth quarter 2025
26/01	Sweden's C-Rad Names New CEO
26/01	C-Rad appoints Tomas Blomquist as CEO
26/01	Tomas Blomquist appointed new CEO of C-RAD
26/01	C-Rad AB Announces CEO Changes
22/10/25	C-RAD has decided to repurchase own class B shares
22/10/25	C-Rad Q3 Ebit up at SEK 21.2 mln
22/10/25	C-Rad CEO to leave
21/10/25	C-Rad AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
21/10/25	C-RAD ABs Interim Report Q3 2025
21/10/25	C-RAD advances approval of interim report for Q3 2025
21/10/25	C-RAD's CEO leaves, CFO Linda Frölén appointed acting CEO, Johan Danielsson is appointed deputy CEO